I think that what we’ve learned so far about genes, genetics in pharmacology, that’s going to be the wave of the future. What I envision seeing, and I’m sure you’ve heard this — but I read a lot, I talk to a lot of people. What I envision seeing, I think in 25 years, I really do, that as soon as a newborn comes to be, or even maternally, a newborn will be tested with a small sample, maybe cheek cells or something very non-invasive. The entire genome will be analyzed. Every defect that there is in the gene will be noticed, and then it will be very clear as to what needs to be done to prevent that gene from developing. That is, to correct the genetic defect so that person may not develop Alzheimer’s disease. That person may not develop high blood pressure or whatever. I really see that coming. And that is going to be great for treating disease, preventing disease, but it will create other problems, because you’re going to have a lot of 150-year-olds around. What are we going to do with all these people who are over 100 years old once we develop to that stage? But you can’t let that limit your development. I think what you need to do first is try to prevent disease, treat disease so that humans can live a healthy lifestyle. I mean the purpose is not to keep a human alive as long as possible. No, no, no. Why should someone die at the age of 55 for heart disease? Why should someone at 60 develop Alzheimer’s disease? If all those diseases can be avoided, I think everyone would live to 100 or 110 but live a very useful life until then. I see nothing wrong with that.